NIH seeks synthesis of cyclopentane monomers and preclinical studies.
The National Institutes of Health (NIH) intends to procure synthesis of cyclopentane monomers, SAMT-247, and related preclinical studies. The work involves chemical synthesis and testing for preclinical research. The buyer is the NIH, serving its research mission. No specific qualifications or set-asides are mentioned. The scale and duration are not specified.
Open the official notice for the full requirements, documents and submission details.
View original noticeOr start a response in qlows